newsfilter
← Latest News
Business Wire·

Kezar Life Sciences Announces 1-for-10 Reverse Stock Split

Kezar Life Sciences, Inc. (NASDAQ:KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that it will conduct a